Colchicine for Prevention of Post-Operative Atrial Fibrillation: A New Indication for a Very Old Drug?

Por Van Wagoner, David R.
Publicado em 2011

Multi-channel blockers for treatment of atrial fibrillation: an effective strategy?

Por Van Wagoner, David R.
Publicado em 2013

Fish oil for atrial fibrillation prevention: Can we intervene soon enough to make a difference?

Por Van Wagoner, David R.
Publicado em 2012

Are SK Channels a Logical Target for Treating Ventricular Arrhythmias? First, do no harm…

Por Van Wagoner, David R.
Publicado no Trends Cardiovasc Med (2015)

Oxidant and inflammatory mechanisms and targeted therapy in AF: An update

Por Gutierrez, Alejandra, Van Wagoner, David R.
Publicado no J Cardiovasc Pharmacol (2015)

Diet and Atrial Fibrillation: Does α‐Linolenic Acid, A Plant Derived Essential Fatty Acid, Have An Impact?

Por Kastner, Devera W., Van Wagoner, David R.
Publicado em 2013

Phosphodiesterase-4 Activity: A Critical Modulator of Atrial Contractility and Arrhythmogenesis()

Por Van Wagoner, David R., Lindsay, Bruce D.
Publicado em 2012

There Is Power in Numbers—Even/Especially in Genomic Medicine

Por Van Wagoner, David R., Chung, Mina K.
Publicado em 2012

How Does Diazoxide Elicit Arrhythmias in Rats With Type 2 Diabetes?: Is This Effect Clinically Significant?()

Por Nelson, Blake W., Van Wagoner, David R.
Publicado no J Am Coll Cardiol (2015)

Baroreflex stimulation vs. renal denervation for treatment of hypertension: what constitutes a logical comparison of these interventions on atrial electrophysiology?

Por Mayyas, Fadia, Sturey, Tiffany, Van Wagoner, David R.
Publicado em 2013

What currents underlie pulmonary vein automaticity?

Por Gore-Panter, Shamone R., Van Wagoner, David R.
Publicado no J Cardiovasc Electrophysiol (2015)

Role of Inflammation in Atrial Fibrillation Pathophysiology and Management

Por Harada, Masahide, Van Wagoner, David R., Nattel, Stanley
Publicado no Circ J (2015)

Impact of aldosterone antagonists on the substrate for atrial fibrillation: Aldosterone promotes oxidative stress and atrial structural/electrical remodeling

Por Mayyas, Fadia, Alzoubi, Karem H., Van Wagoner, David R.
Publicado em 2013

L-Type calcium channel blockers exert an anti-inflammatory effect by suppressing expression of plasminogen receptors on macrophages

Por Das, Riku, Burke, Tim, Van Wagoner, David R., Plow, Edward F.
Publicado em 2009

Preoperative Angiotensin Blocking Drug Therapy Is not Associated with Atrial Fibrillation after Cardiac Surgery

Por Rader, Florian, Van Wagoner, David R., Gillinov, A. Marc, Blackstone, Eugene H.
Publicado em 2010

Cardiac Autonomic Nerve Stimulation in the Treatment of Heart Failure

Por Kobayashi, Mariko, Massiello, Alex, Karimov, Jamshid H., Van Wagoner, David R., Fukamachi, Kiyotaka
Publicado em 2013

Is Left Atrial Size a Predictor of Mortality after Coronary Artery Bypass Surgery? A Single Center Study

Por Ibrahim, Khalid S., Mayyas, Fadia A., Kheirallah, Khalid, AlWaqfi, Nizar R., Van Wagoner, David R.
Publicado no Acta Cardiol Sin (2017)

Elucidation of a TRPC6-TRPC5 Channel Cascade That Restricts Endothelial Cell Movement

Por Chaudhuri, Pinaki, Colles, Scott M., Bhat, Manjunatha, Van Wagoner, David R., Birnbaumer, Lutz, Graham, Linda M.
Publicado em 2008

Rapid Multi-Slice T(1) Mapping of Mouse Myocardium: Application to Quantification of Manganese Uptake in α-Dystrobrevin Knockout Mice

Por Jiang, Kai, Li, Wen, Li, Wei, Jiao, Sen, Castel, Laurie, Van Wagoner, David R., Yu, Xin
Publicado no Magn Reson Med (2014)

Impact of Vagal Nerve Stimulation on Left Atrial Structure and Function in a Canine High-Rate Pacing Model

Por Kusunose, Kenya, Zhang, Youhua, Mazgalev, Todor N., Van Wagoner, David R., Thomas, James D., Popović, Zoran B.
Publicado em 2014